BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 27421702)

  • 21. Natural killer cell intrinsic toll-like receptor MyD88 signaling contributes to IL-12-dependent IFN-γ production by mice during infection with Toxoplasma gondii.
    Ge Y; Chen J; Qiu X; Zhang J; Cui L; Qi Y; Liu X; Qiu J; Shi Z; Lun Z; Shen J; Wang Y
    Int J Parasitol; 2014 Jun; 44(7):475-84. PubMed ID: 24727091
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Type 1 Innate Lymphoid Cells Protect Mice from Acute Liver Injury via Interferon-γ Secretion for Upregulating Bcl-xL Expression in Hepatocytes.
    Nabekura T; Riggan L; Hildreth AD; O'Sullivan TE; Shibuya A
    Immunity; 2020 Jan; 52(1):96-108.e9. PubMed ID: 31810881
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Type 1 cytokine/chemokine production by mouse NK cells following activation of their TLR/MyD88-mediated pathways.
    Sawaki J; Tsutsui H; Hayashi N; Yasuda K; Akira S; Tanizawa T; Nakanishi K
    Int Immunol; 2007 Mar; 19(3):311-20. PubMed ID: 17289654
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activation of mouse liver natural killer cells and NK1.1(+) T cells by bacterial superantigen-primed Kupffer cells.
    Dobashi H; Seki S; Habu Y; Ohkawa T; Takeshita S; Hiraide H; Sekine I
    Hepatology; 1999 Aug; 30(2):430-6. PubMed ID: 10421651
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An accessory role for B cells in the IL-12-induced activation of resting mouse NK cells.
    Haddad EA; Senger LK; Takei F
    J Immunol; 2009 Sep; 183(6):3608-15. PubMed ID: 19710462
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Autocrine regulation of IL-12 receptor expression is independent of secondary IFN-gamma secretion and not restricted to T and NK cells.
    Thibodeaux DK; Hunter SE; Waldburger KE; Bliss JL; Trepicchio WL; Sypek JP; Dunussi-Joannopoulos K; Goldman SJ; Leonard JP
    J Immunol; 1999 Nov; 163(10):5257-64. PubMed ID: 10553047
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interleukin-10 suppresses natural killer cell but not natural killer T cell activation during bacterial infection.
    Scott MJ; Hoth JJ; Turina M; Woods DR; Cheadle WG
    Cytokine; 2006 Jan; 33(2):79-86. PubMed ID: 16488621
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Natural killer cell cytokine production, not cytotoxicity, contributes to resistance against blood-stage Plasmodium chabaudi AS infection.
    Mohan K; Moulin P; Stevenson MM
    J Immunol; 1997 Nov; 159(10):4990-8. PubMed ID: 9366426
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combined stimulation with interleukin-18 and CpG induces murine natural killer dendritic cells to produce IFN-gamma and inhibit tumor growth.
    Chaudhry UI; Kingham TP; Plitas G; Katz SC; Raab JR; DeMatteo RP
    Cancer Res; 2006 Nov; 66(21):10497-504. PubMed ID: 17079471
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rapid interferon-gamma release from natural killer cells induced by a streptococcal commensal.
    Bouwer AL; Saunderson SC; Dunn AC; Lester KL; Crowley LR; Jack RW; McLellan AD
    J Interferon Cytokine Res; 2013 Aug; 33(8):459-66. PubMed ID: 23659669
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Circulating CD56dim natural killer cells and CD56+ T cells that produce interferon-γ or interleukin-10 are expanded in asymptomatic, E antigen-negative patients with persistent hepatitis B virus infection.
    Conroy MJ; Mac Nicholas R; Grealy R; Taylor M; Otegbayo JA; O'Dea S; Mulcahy F; Ryan T; Norris S; Doherty DG
    J Viral Hepat; 2015 Mar; 22(3):335-45. PubMed ID: 25186004
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential cytokine and chemokine gene expression by human NK cells following activation with IL-18 or IL-15 in combination with IL-12: implications for the innate immune response.
    Fehniger TA; Shah MH; Turner MJ; VanDeusen JB; Whitman SP; Cooper MA; Suzuki K; Wechser M; Goodsaid F; Caligiuri MA
    J Immunol; 1999 Apr; 162(8):4511-20. PubMed ID: 10201989
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity.
    Trinchieri G
    Annu Rev Immunol; 1995; 13():251-76. PubMed ID: 7612223
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential recruitment and activation of natural killer cell sub-populations by Mycobacterium bovis-infected dendritic cells.
    Siddiqui N; Hope J
    Eur J Immunol; 2013 Jan; 43(1):159-69. PubMed ID: 23124835
    [TBL] [Abstract][Full Text] [Related]  

  • 35. IL-12 is essential for resistance against Yersinia enterocolitica by triggering IFN-gamma production in NK cells and CD4+ T cells.
    Bohn E; Autenrieth IB
    J Immunol; 1996 Feb; 156(4):1458-68. PubMed ID: 8568248
    [TBL] [Abstract][Full Text] [Related]  

  • 36. NK Cells Alleviate Lung Inflammation by Negatively Regulating Group 2 Innate Lymphoid Cells.
    Bi J; Cui L; Yu G; Yang X; Chen Y; Wan X
    J Immunol; 2017 Apr; 198(8):3336-3344. PubMed ID: 28275135
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of γδ T cells in α-galactosylceramide-mediated immunity.
    Paget C; Chow MT; Duret H; Mattarollo SR; Smyth MJ
    J Immunol; 2012 Apr; 188(8):3928-39. PubMed ID: 22412194
    [TBL] [Abstract][Full Text] [Related]  

  • 38. T and B lymphocytes exert distinct effects on the homeostasis of NK cells.
    Jeannet G; Coudert JD; Held W
    Eur J Immunol; 2006 Oct; 36(10):2725-34. PubMed ID: 16955521
    [TBL] [Abstract][Full Text] [Related]  

  • 39. TWEAK attenuates the transition from innate to adaptive immunity.
    Maecker H; Varfolomeev E; Kischkel F; Lawrence D; LeBlanc H; Lee W; Hurst S; Danilenko D; Li J; Filvaroff E; Yang B; Daniel D; Ashkenazi A
    Cell; 2005 Dec; 123(5):931-44. PubMed ID: 16325585
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rapid generation of potent and tumor-specific cytotoxic T lymphocytes by interleukin 18 using dendritic cells and natural killer cells.
    Tanaka F; Hashimoto W; Okamura H; Robbins PD; Lotze MT; Tahara H
    Cancer Res; 2000 Sep; 60(17):4838-44. PubMed ID: 10987295
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.